Inventor · disambiguated record
Simon Osborne
Also filed as: OSBORNE SIMON · OSBORNE SIMON ANDREW
7 granted patents·5 pending applications·53 citations·filing 1994–2023
81Inventor score
Top patents by PatentIndex Score
12 records- 0184US6057357APeripherally selective kappa opioid agonistsWARNER LAMBERT CO·Filed 1998·Granted May 2, 2000·36 cites·14 claims
- 0269US6689906B1Bicyclic amino acids as pharmaceutical agentsWARNER LAMBERT CO·Filed 2000·Granted Feb 10, 2004·4 cites·16 claims
- 0360US2024239790A17-Morpholino-1,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK InhibitorADMARE THERAPEUTICS SOC·Filed 2022·Application pending·0 cites
- 0460US2024246960A17-Morpholino-L,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK InhibitorADMARE THERAPEUTICS SOC·Filed 2022·Application pending·0 cites
- 0558US2025136577A1Heterocyclic derivatives as malt1 inhibitorsC4X DISCOVERY LTD·Filed 2023·Application pending·0 cites
- 0654US6835751B2Bicyclic amino acids as pharmaceutical agentsWARNER LAMBERT CO·Filed 2004·Granted Dec 28, 2004·0 cites·3 claims
- 0754US2025326754A1DNA-PK Inhibitor Compounds and Uses ThereofADMARE THERAPEUTICS SOC·Filed 2023·Application pending·0 cites
- 0850US2024208934A1Ulk1/2 inhibitors and their use thereofLIFEARC·Filed 2022·Application pending·0 cites
- 0949US6133307ACertain benzofuranyl-N-[pyrrolidin-1-YL]-N-methyl-acetamide derivatives useful as opioid agonistsWARNER LAMBERT CO·Filed 1998·Granted Oct 17, 2000·4 cites·12 claims
- 1048US5554644ATachykinin (NK2) antagonistsWARNER LAMBERT CO·Filed 1994·Granted Sep 10, 1996·9 cites·9 claims
- 1140US10961234B2Oxazole derivatives for use in the treatment of cancerLIFEARC·Filed 2017·Granted Mar 30, 2021·0 cites·26 claims
- 1240US10961233B2Oxazole derivatives for use in the treatment of cancerLIFEARC·Filed 2017·Granted Mar 30, 2021·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Simon Osborne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →